GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

151

Serum Tyrosine, HCC and mortality

Serum Tyrosine, Hepatocellular Carcinoma (HCC), and Mortality: Detailed Explanation What is Serum Tyrosine? Serum tyrosine is an aromatic amino acid (AAA) that plays a critical role in protein...

152

CEACAM6, HOXA-AS3 and miR-29a in colorectal cancer

CEACAM6, HOXA-AS3, and miR-29a are molecular components that play significant roles in colorectal cancer (CRC) progression, diagnosis, prognosis, and potential therapeutic strategies. Below is a detailed explanation of...

153

CD47 expression on survival of colorectal cancer

CD47 expression plays a significant role in determining the survival outcomes of colorectal cancer (CRC) patients. Here's a detailed explanation of its impact: What is CD47? CD47 is...

154

AFP-L3 or DCP expression is associated with poor outcomes in unresectable HCC

Yes, the expression of AFP-L3 or DCP is strongly associated with poor outcomes in patients with unresectable hepatocellular carcinoma (HCC), as demonstrated by the study you referenced. Here's...

155

MIER2 as a prognostic marker in colon adenocarcinoma

MIER2 as a Prognostic Marker in Colon Adenocarcinoma (COAD) What is MIER2? Mesoderm Induction Early Response 2 (MIER2) is a gene that has been identified to play a...

156

Ferroptosis and enhances immunotherapy in pancreatic cancer

Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative damage, has emerged as a potential mechanism to overcome the resistance of pancreatic ductal...

157

MATTERHORN Trial

The MATTERHORN trial was a global, Phase 3 study that investigated the addition of Durvalumab (an immunotherapy drug) to the standard FLOT chemotherapy regimen in patients with resectable...

158

Top 10 GI Oncology Studies at ESMO 2025

Based on the context provided, here are the top 10 gastrointestinal (GI) oncology studies that could be highlighted at ESMO 2025 based on their significant findings, clinical implications,...

159

Prognostic and Predictive Impact of HER2 Alterations in mCRC Treated with Chemotherapy–Bevacizumab vs Anti-EGFR Therapy

The prognostic and predictive impact of HER2 alterations (amplification or mutation) in metastatic colorectal cancer (mCRC) was evaluated through a pooled analysis of eight major randomized clinical trials,...

160

HCC outcome at the age of 80 and beyond with RF Ablation

The study conducted at Musashino Red Cross Hospital in Tokyo evaluated the effectiveness and safety of radiofrequency ablation (RFA) for treating hepatocellular carcinoma (HCC) in patients aged 80...

Previous
115161718
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer